Pfohl, M., Siegmund, T., Pscherer, S., Pegelow, K., & Seufert, J. (2015). Effectiveness and tolerability of treatment intensification to basal–bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: The PARTNER observational study. Vasc Health Risk Manag.
Citação norma ChicagoPfohl, Martin, Thorsten Siegmund, Stefan Pscherer, Katrin Pegelow, and Jochen Seufert. "Effectiveness and Tolerability of Treatment Intensification to Basal–bolus Therapy in Patients With Type 2 Diabetes On Previous Basal Insulin-supported Oral Therapy With Insulin Glargine or Supplementary Insulin Therapy With Insulin Glulisine: The PARTNER Observational Study." Vasc Health Risk Manag 2015.
Citação norma MLAPfohl, Martin, et al. "Effectiveness and Tolerability of Treatment Intensification to Basal–bolus Therapy in Patients With Type 2 Diabetes On Previous Basal Insulin-supported Oral Therapy With Insulin Glargine or Supplementary Insulin Therapy With Insulin Glulisine: The PARTNER Observational Study." Vasc Health Risk Manag 2015.